fig1
![Genomic alterations and targeted therapies in extrahepatic cholangiocarcinoma](https://image.oaes.cc/178b0dc7-6d61-4d3e-9c0d-c7b2538b94b3/5853.fig.1.jpg)
Figure 1. Molecular classification of extrahepatic cholangiocarcinoma.Tumor and microenvironment molecular features of transcriptome-based Metabolic, Proliferation, Mesenchymal and Immune classes discovered in eCCA[38]. Candidate targeted therapies with a potential benefit in Proliferation and Immune classes are proposed. Figure adapted from Montal et al. J. Hepatol 2020[38].